share_log

Cantor Fitzgerald Maintains Overweight on Mesoblast, Lowers Price Target to $17

Benzinga ·  Aug 31, 2023 09:19

Cantor Fitzgerald analyst Louise Chen maintains Mesoblast (NASDAQ:MESO) with a Overweight and lowers the price target from $23 to $17.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment